LY2886721 5 mg | 99.94%
TargetMol
LY2886721, a BACE inhibitor, is used for the therapy of Alzheimer’s Disease.
More Information Supplier PageLY2886721
Search Results
LY2886721 50 mg | 99.94%
TargetMol
LY2886721, a BACE inhibitor, is used for the therapy of Alzheimer’s Disease.
More Information Supplier PageLY2886721
EPZ015666 10 mg | 99.29%
TargetMol
EPZ015666 is an orally available inhibitor of PRMT5 enzymatic activity.
More Information Supplier PageEPZ015666
EPZ015666 2 mg | 99.29%
TargetMol
EPZ015666 is an orally available inhibitor of PRMT5 enzymatic activity.
More Information Supplier PageEPZ015666
AZD 6482 5 mg | 99.95%
TargetMol
AZD 6482 is a potent and selective p110β inhibitor with IC50 of 0.69 nM and a PI3Kβ inhibitor with IC50 of 10 nM.
More Information Supplier PageAZD 6482
AZD 6482 50 mg | 99.95%
TargetMol
AZD 6482 is a potent and selective p110β inhibitor with IC50 of 0.69 nM and a PI3Kβ inhibitor with IC50 of 10 nM.
More Information Supplier PageAZD 6482
AZD 6482 2 mg | 99.95%
TargetMol
AZD 6482 is a potent and selective p110β inhibitor with IC50 of 0.69 nM and a PI3Kβ inhibitor with IC50 of 10 nM.
More Information Supplier PageAZD 6482
AZD 6482 25 mg | 99.95%
TargetMol
AZD 6482 is a potent and selective p110β inhibitor with IC50 of 0.69 nM and a PI3Kβ inhibitor with IC50 of 10 nM.
More Information Supplier PageAZD 6482
AZD 6482 10 mg | 99.95%
TargetMol
AZD 6482 is a potent and selective p110β inhibitor with IC50 of 0.69 nM and a PI3Kβ inhibitor with IC50 of 10 nM.
More Information Supplier PageAZD 6482
EPZ015666 5 mg | 99.29%
TargetMol
EPZ015666 is an orally available inhibitor of PRMT5 enzymatic activity.
More Information Supplier PageEPZ015666